We are live on ! Find out more
MLAB icon

Mesa Laboratories

159 hedge funds and large institutions have $1.28B invested in Mesa Laboratories in 2021 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 63 increasing their positions, 57 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more capital invested

Capital invested by funds: $1.12B → $1.28B (+$153M)

11% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 57

1.69% more ownership

Funds ownership: 89.9%91.59% (+1.7%)

8% less funds holding

Funds holding: 173159 (-14)

48% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 29

Holders
159
Holders Change
-14
Holders Change %
-8.09%
% of All Funds
2.77%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
15
Increased
63
Reduced
57
Closed
29
Calls
Puts
Net Calls
Net Calls Change

MLAB Hedge Fund Activity: Q2 2021 in Review

159 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q2 2021, worth a combined $1.28B — up 14% from $1.12B a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of MLAB and 15 opened new positions — a net loss of 14 holders — while 57 trimmed existing stakes and 63 added.

The largest buyer was BlackRock, adding an estimated $29M. The largest seller was T. Rowe Price Associates, cutting an estimated $9.51M.

  • 159 institutional investors held Mesa Laboratories (MLAB) as of Q2 2021, down from 173 in Q1 2021.
  • Funds reported $1.28B of Mesa Laboratories stock for Q2 2021, up 14% quarter-over-quarter.
  • 15 funds opened new Mesa Laboratories positions in Q2 2021 and 29 closed out, a net change of -14 holders.
  • The largest Mesa Laboratories buyer in Q2 2021 was BlackRock, an estimated $29M added.
  • The largest Mesa Laboratories seller in Q2 2021 was T. Rowe Price Associates, an estimated $9.51M sold.

Based on aggregated 13F filings for Q2 2021.